Cargando…

Radiological and Clinical Value of 7T MRI for Evaluating 3T-Visible Lesions in Pharmacoresistant Focal Epilepsies

Objective: The recent FDA approval of the first 7T MRI scanner for clinical diagnostic use in October 2017 will likely increase the utilization of 7T for epilepsy presurgical evaluation. This study aims at accessing the radiological and clinical value of 7T in patients with pharmacoresistant focal e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Z. Irene, Oh, Se-Hong, Lowe, Mark, Larvie, Mykol, Ruggieri, Paul, Hill, Virginia, Statsevych, Volodymyr, Moon, Doksu, Lee, Jonathan, Emch, Todd, Bena, James, Blümcke, Ingmar, Bingaman, William, Gonzalez-Martinez, Jorge A., Najm, Imad, Jones, Stephen E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960771/ https://www.ncbi.nlm.nih.gov/pubmed/33737901 http://dx.doi.org/10.3389/fneur.2021.591586

Ejemplares similares

Evaluating whole‐brain tissue‐property changes in MRI‐negative pharmacoresistant focal epilepsies using MR fingerprinting
por: Su, Ting‐Yu, et al.
Publicado: (2022)

Cortical stimulation in pharmacoresistant focal epilepsies
por: Ellrich, Jens
Publicado: (2020)

Cytochrome P450-mediated antiseizure medication interactions influence apoptosis, modulate the brain BAX/Bcl-X(L) ratio and aggravate mitochondrial stressors in human pharmacoresistant epilepsy
por: Ghosh, Chaitali, et al.
Publicado: (2022)

An introduction to the mini‐symposium on “The Neuropathology of Focal Human Epilepsy”
por: Blümcke, Ingmar
Publicado: (2021)

7T MRI with post-processing for the presurgical evaluation of pharmacoresistant focal epilepsy
por: Chen, Cong, et al.
Publicado: (2021)

Histopathologic substrate of drug‐resistant epilepsy in older adults and the elderly undergoing surgery
por: Punia, Vineet, et al.
Publicado: (2019)

Toward a refined genotype–phenotype classification scheme for the international consensus classification of Focal Cortical Dysplasia
por: Blumcke, Ingmar, et al.
Publicado: (2021)

Effects of Surgical Side and Site on Mood and Behavior Outcome in Children with Pharmacoresistant Epilepsy
por: Andresen, Elizabeth N., et al.
Publicado: (2014)

Altered structural connectome in non-lesional newly diagnosed focal epilepsy: Relation to pharmacoresistance
por: Kreilkamp, Barbara A.K., et al.
Publicado: (2021)

Genetic variations associated with pharmacoresistant epilepsy
por: Cárdenas-Rodríguez, Noemí, et al.
Publicado: (2020)

Pyogenic brain abscess, ventriculitis and diffuse meningitis with fatal outcome in an adult: Radiologic–pathologic correlation(☆,#)()()
por: Mahammedi, Abdelkader, et al.
Publicado: (2018)

Vagal nerve stimulation for pharmacoresistant epilepsy in children
por: Hauptman, Jason S., et al.
Publicado: (2012)

Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2022)

Cognitive Processing Impacts High Frequency Intracranial EEG Activity of Human Hippocampus in Patients With Pharmacoresistant Focal Epilepsy
por: Cimbalnik, Jan, et al.
Publicado: (2020)

Past Trauma Is Associated With a Higher Risk of Experiencing an Epileptic Seizure as Traumatic in Patients With Pharmacoresistant Focal Epilepsy
por: Mariotti, Sara, et al.
Publicado: (2021)

Pharmacoresistant Abdominal Seizures in Symptomatic Localization-Related Epilepsy
por: Tushar, Vadakke Puthanveetil, et al.
Publicado: (2021)

The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies
por: Fattorusso, Antonella, et al.
Publicado: (2021)

Transporter hypothesis in pharmacoresistant epilepsies. Is it at the central or peripheral level?
por: Czornyj, Liliana, et al.
Publicado: (2021)

Corrigendum: Improving therapy of pharmacoresistant epilepsies: The role of fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2023)

Molecular and subregion mechanisms of episodic memory phenotypes in temporal lobe epilepsy
por: Busch, Robyn M, et al.
Publicado: (2022)

Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance
por: Grewal, Gurpreet Kaur, et al.
Publicado: (2017)

A complex systems view on the current hypotheses of epilepsy pharmacoresistance
por: Servilha‐Menezes, Gabriel, et al.
Publicado: (2022)

Lower fat and better quality diet therapy for children with pharmacoresistant epilepsy
por: Yoon, Jung-Rim, et al.
Publicado: (2013)

‘Hippocampal innate inflammatory gliosis only’ in pharmacoresistant temporal lobe epilepsy
por: Grote, Alexander, et al.
Publicado: (2022)

Limbic network co‐localization predicts pharmacoresistance in dysplasia‐related epilepsy
por: Cohen, Nathan T., et al.
Publicado: (2023)

Topography and Determinants of Magnetic Resonance Imaging (MRI)‐Visible Perivascular Spaces in a Large Memory Clinic Cohort
por: Shams, Sara, et al.
Publicado: (2017)

Quantitative Analysis of Metabolic Abnormality Associated with Brain Developmental Venous Anomalies
por: Timerman, Dmitriy, et al.
Publicado: (2016)

Incorporation of quantitative MRI in a model to predict temporal lobe epilepsy surgery outcome
por: Morita-Sherman, Marcia, et al.
Publicado: (2021)

Extra operative intracranial EEG monitoring for epilepsy surgery in elderly patients()
por: Punia, Vineet, et al.
Publicado: (2018)

Different pharmacoresistance of focal epileptic spasms, generalized epileptic spasms, and generalized epileptic spasms combined with focal seizures
por: Takahashi, Yukitoshi, et al.
Publicado: (2021)

Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program
por: Contin, Manuela, et al.
Publicado: (2021)

Pharmacoresistant Epilepsy in Childhood: Think of the Cerebral Folate Deficiency, a Treatable Disease
por: Mafi, Sarah, et al.
Publicado: (2020)

Gephyrin and CYP2C9 Genetic Polymorphisms in Patients with Pharmacoresistant Epilepsy
por: El-Tallawy, Hamdy N, et al.
Publicado: (2021)

Network Substrates of Centromedian Nucleus Deep Brain Stimulation in Generalized Pharmacoresistant Epilepsy
por: Torres Diaz, Cristina V., et al.
Publicado: (2021)

Multi‐omic strategies applied to the study of pharmacoresistance in mesial temporal lobe epilepsy
por: Bruxel, Estela M., et al.
Publicado: (2021)

Growth-associated protein 43 and progressive epilepsy in cortical dysplasia
por: Ying, Zhong, et al.
Publicado: (2014)

Incidence and prevalence of major epilepsy-associated brain lesions
por: López-Rivera, Javier A., et al.
Publicado: (2022)

Time to push the age limit: Epilepsy surgery in patients 60 years or older
por: Punia, Vineet, et al.
Publicado: (2018)

MRI of focal cortical dysplasia
por: Urbach, Horst, et al.
Publicado: (2021)

Pharmacoresistant Epilepsy: A Current Update on Non-Conventional Pharmacological and Non-Pharmacological Interventions
por: Sharma, Arun Kumar, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tb1e48t853b9uc56kipds6u8ah